Bhumibol Adulyadej Hospital is a hospital located in Sai Mai District, Bangkok, Thailand. It is a military hospital operated by the Directorate of Medical Services, The Royal Thai Air Force particularly for personnel of the Royal Thai Air Force, but also for the general public.

There are 694 beds in Bhumibol Adulyadej Hospital.

During the past decade, Bhumibol Adulyadej Hospital conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 4 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bhumibol Adulyadej Hospital" #1 sponsor was "Institut de Recherche pour le Developpement" with 5 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials sponsored, "Shenyang Sunshine Pharmaceutical Co., LTD." with 2 trials sponsored, "The HIV Netherlands Australia Thailand Research Collaboration" with 2 trials sponsored and "AO Innovation Translation Center" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bhumibol Adulyadej Hospital" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 4 trials as a collaborator, "Bhumibol Adulyadej Hospital" with 3 trials as a collaborator, "Klang Hospital" with 2 trials as a collaborator, "Navitas Life Sciences GmbH" with 2 trials as a collaborator and "Bamrasnaradura Infectious Diseases Institute" with 1 trials as a collaborator. Other collaborators include 36 different institutions and companies that were collaborators in the rest 46 trials.

According to Clinical.Site data, the most researched conditions in "Bhumibol Adulyadej Hospital" are "HIV Infections" (5 trials), "Atrial Fibrillation" (2 trials), "Caloric Deficit" (1 trials), "Cervical Cancer" (1 trials) and "Coronary Artery Disease" (1 trials). Many other conditions were trialed in "Bhumibol Adulyadej Hospital" in a lesser frequency.

Most popular intervention types in "Bhumibol Adulyadej Hospital" are "Drug" (13 trials), "Device" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "EPIAO®" (2 trials), "EPREX®" (2 trials), "Lopinavir/ritonavir" (2 trials), "Carboplatin" (1 trials) and "Cisplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bhumibol Adulyadej Hospital" are 11 trials for "All" genders and 7 trials for "Female" genders.

Currently, there are NaN active trials in "Bhumibol Adulyadej Hospital". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Bhumibol Adulyadej Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Bhumibol Adulyadej Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".